United Therapeutics (UTHR) Shares Edge Higher as Wedbush Upgrades to Outperform

Article Stock Quotes (1) Comments (0)

Shares of United Therapeutics Corp. (NASDAQ: UTHR) have ticked higher in intraday action as an analyst at Wedbush just upgraded the stock from Neutral to Outperform. The firm also boosted its price target from $79 to $94.

Traders in UTHR shares are responding to Q1 results from the company Thursday morning.

With the stock last trading at $68.92 (down 2.5 percent from Wednesday's close), Wedbush's new price target suggests potential upside of about 36 percent.

For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
• Goldman Sachs Upgrades Meritor (MTOR) to Buy
• Macquarie Upgrades IntercontinentalExchange (ICE) to Outperform

Create E-mail Alert Related Categories

Upgrades

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?